Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score Impact of Complete Surgery of Colorectal Deep Infiltrating Endometriosis on Fertility 10/31/2016 INTERVENTIONAL unchanged 3,586.85 0 Preoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast Cancer 11/04/2016 INTERVENTIONAL unchanged 3,582.85 0 Screening Study for Cervical Pre-cancer and Cancer Prevention in South African Women. 11/04/2016 OBSERVATIONAL unchanged 3,582.85 0 Hypofractionated Radiation Therapy for Patients With Breast Cancer Receiving Regional Nodal Irradiation 11/08/2016 INTERVENTIONAL unchanged 3,578.85 0 Composite Outcomes of Mesh vs Suture Techniques for Prolapse Repair: A Randomized Controlled Multicentre Trial 11/16/2016 INTERVENTIONAL unchanged 3,570.85 0 Trial of Maternal Oxygen for Fetal Left Heart Hypoplasia 11/17/2016 INTERVENTIONAL unchanged 3,569.85 0 Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of DMD and BMD 11/23/2016 OBSERVATIONAL unchanged 3,563.85 0 Use of Sildenafil for Treatment of Urinary Incontinence 12/06/2016 INTERVENTIONAL unchanged 3,550.85 0 Feto-Endoscopic Tracheal Occlusion (FETO) for Severe Congenital Diaphragmatic Hernia 12/08/2016 INTERVENTIONAL unchanged 3,548.85 0 Progesterone to Enhance the Efficacy and Success of Expectantly Managed Preterm Severe/Superimposed Preeclampsia 12/12/2016 INTERVENTIONAL unchanged 3,544.85 0 Trial Evaluating Role of Post Mastectomy Radiotherapy in Women With Node Negative Early Breast Cancer 12/14/2016 INTERVENTIONAL unchanged 3,542.85 0 Image-Guided Gynecologic Brachytherapy 12/15/2016 INTERVENTIONAL unchanged 3,541.85 0 PPROM Registry (Preterm Premature Rupture of Membranes) 12/20/2016 OBSERVATIONAL unchanged 3,536.85 0 Exercise Interventions for Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy 12/21/2016 INTERVENTIONAL unchanged 3,535.85 0 The prEgnanCy and eArly Childhood nutrItion triaL (ECAIL) 12/26/2016 INTERVENTIONAL unchanged 3,530.85 0 A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma 01/02/2017 INTERVENTIONAL unchanged 3,523.85 0 Prognostic and Predictive Biomarkers in Ovarian Cancers 01/04/2017 INTERVENTIONAL unchanged 3,521.85 0 Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial 01/05/2017 INTERVENTIONAL unchanged 3,520.85 0 Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer 01/06/2017 INTERVENTIONAL unchanged 3,519.85 0 Hypnosedation in Relaxing Patients Undergoing Breast Cancer Surgery 01/06/2017 INTERVENTIONAL unchanged 3,519.85 0 Study of Niraparib and TSR-042 in Recurrent Endometrial Cancer 01/10/2017 INTERVENTIONAL unchanged 3,515.85 0 Genetically Modified T Cells and Decitabine in Treating Patients With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer 01/11/2017 INTERVENTIONAL unchanged 3,514.85 0 Heart Attack Research Program: Platelet Sub-Study (HARP) 01/16/2017 OBSERVATIONAL unchanged 3,509.85 0 Two Therapeutic Strategies in First-line in Patients With Epithelial Advanced Ovarian Cancer 01/19/2017 INTERVENTIONAL unchanged 3,506.85 0 Texting for Diabetes 01/20/2017 INTERVENTIONAL unchanged 3,505.85 0 Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer 01/24/2017 INTERVENTIONAL unchanged 3,501.85 0 Hysterectomy and OPPortunistic SAlpingectomy 02/08/2017 INTERVENTIONAL unchanged 3,486.85 0 Electrophysiology of Fetal Arrhythmia 02/08/2017 OBSERVATIONAL unchanged 3,486.85 0 Video-Feedback Interaction Guidance for Improving Interactions Between Depressed Mothers and Their Infants ("VID-KIDS") 02/14/2017 INTERVENTIONAL unchanged 3,480.85 0 Materiovigilance After Urinary Incontinence or Prolapse Surgery 02/14/2017 OBSERVATIONAL unchanged 3,480.85 0 Comparison of the Efficacy of Sacrocolpopexy, the Amreich-Richter Procedure and Transvaginal Mesh 02/15/2017 INTERVENTIONAL unchanged 3,479.85 0 Interest of Myo-inositol Supplementation in Women With Polycystic Ovarian Syndrome 02/23/2017 INTERVENTIONAL unchanged 3,471.85 0 Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer. 02/23/2017 INTERVENTIONAL unchanged 3,471.85 0 Validation of Human Papillomavirus Assays and Collection Devices for Self-samples and Urine Samples 02/24/2017 OBSERVATIONAL unchanged 3,470.85 0 Hyperandrogenemia and Altered Day-night LH Pulse Patterns 03/03/2017 INTERVENTIONAL unchanged 3,463.85 0 PORTAL: Patient-reported Outcomes After Routine Treatment of Atypical Lesions 03/03/2017 INTERVENTIONAL unchanged 3,463.85 0 Vitamin B12 Supplementation During Pregnancy on Cognitive Development 03/07/2017 INTERVENTIONAL unchanged 3,459.85 0 Toxicity and Outcome of Whole Breast Hypofractionated Radiotherapy: a Single Institution Experience 03/10/2017 OBSERVATIONAL unchanged 3,456.85 0 Migraine and CVD Risk in Women 03/16/2017 INTERVENTIONAL unchanged 3,450.85 0 Strategies for Pregnancy Achievement 03/21/2017 INTERVENTIONAL unchanged 3,445.85 0 POWERMOM, A Healthy Pregnancy Research Community 03/21/2017 OBSERVATIONAL unchanged 3,445.85 0 Fetoscopic Repair of Isolated Fetal Spina Bifida 03/27/2017 INTERVENTIONAL unchanged 3,439.85 0 Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response 03/30/2017 INTERVENTIONAL unchanged 3,436.85 0 Study of Food Aversion in Patients With Anorexia Nervosa 04/04/2017 INTERVENTIONAL unchanged 3,431.85 0 Assessment of Gemcitabine as Chemoradiotherapy in Patients With Locally Advanced Carcinoma of Cervix and Renal Disease 04/05/2017 INTERVENTIONAL unchanged 3,430.85 0 Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence 04/07/2017 INTERVENTIONAL unchanged 3,428.85 0 Predictors of Postoperative Pain Following Oocyte Retrieval for Assisted Reproduction 04/10/2017 INTERVENTIONAL unchanged 3,425.85 0 Can Conventional ECG Technology Capture Fetal Cardiac Activity? 04/12/2017 INTERVENTIONAL unchanged 3,423.85 0 The 3D Cohort Study (Design, Develop, Discover) 04/13/2017 OBSERVATIONAL unchanged 3,422.85 0 P53MVA and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer 04/13/2017 INTERVENTIONAL unchanged 3,422.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology